Reports for HYDROCHLOROTHIAZIDE

Ingredient

HYDROCHLOROTHIAZIDE

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-CANDESARTAN/HCTZ 32MG 12.5MG TABLET Resolved 2021-01-28 2021-03-04 132657
TEVA-CANDESARTAN/HCTZ 12.5MG 32MG TABLET Resolved 2022-10-28 2022-12-15 173031
TEVA-CANDESARTAN/HCTZ 12.5MG 32MG TABLET Resolved 2023-10-05 2024-04-05 206425
APO-CILAZAPRIL/HCTZ 12.5MG 5MG TABLET Resolved 2017-03-10 2017-04-04 83
APO-CILAZAPRIL/HCTZ 12.5MG 5MG TABLET Resolved 2018-01-03 2018-08-18 34841
APO-CILAZAPRIL/HCTZ 12.5MG 5MG TABLET Resolved 2022-12-05 2023-02-02 177115
APO-CILAZAPRIL/HCTZ 12.5MG 5MG TABLET Resolved 2023-11-24 2023-12-01 211496
APO-OLMESARTAN/HCTZ 12.5MG 20MG TABLET Resolved 2017-07-25 2018-04-23 16900
APO-OLMESARTAN/HCTZ 12.5MG 20MG TABLET Resolved 2018-07-04 2018-11-22 54303
APO-OLMESARTAN/HCTZ 12.5MG 20MG TABLET Resolved 2018-12-27 2020-07-11 70532

Showing 531 to 540 of 678

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
ALTACE HCT 12.5MG 10MG TABLET Discontinued 2023-12-21 2024-01-09 214024
ALTACE HCT 25MG 10MG TABLET Discontinued 2023-12-21 2024-01-09 214027

Showing 101 to 102 of 102